Gene: PLEKHH3
Official Full Name: pleckstrin homology, MyTH4 and FERM domain containing H3provided by HGNC
Gene Summary: Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15041 | PLEKHH3 Knockout cell line (HeLa) | Human | PLEKHH3 | 1:3~1:6 | Negative | Online Inquiry |
KO15042 | PLEKHH3 Knockout cell line (HCT 116) | Human | PLEKHH3 | 1:2~1:4 | Negative | Online Inquiry |
KO15043 | PLEKHH3 Knockout cell line (HEK293) | Human | PLEKHH3 | 1:3~1:6 | Negative | Online Inquiry |
KO15044 | PLEKHH3 Knockout cell line (A549) | Human | PLEKHH3 | 1:3~1:4 | Negative | Online Inquiry |
PLEKHH3 Gene Knockout Cell Lines are genetically engineered cell models designed to study the specific functions and pathways influenced by the PLEKHH3 gene, which encodes a pleckstrin homology domain-containing protein suspected to play roles in cellular signaling and membrane trafficking. By systematically knocking out this gene, researchers can observe the resulting phenotypic changes and elucidate its biological functions, making it an invaluable tool in molecular and cellular biology.
The primary mechanism of PLEKHH3 knockout involves utilizing CRISPR/Cas9 gene editing technology, which precisely disrupts the PLEKHH3 locus, leading to the absence or significant reduction of the protein product. This loss of function can greatly aid in understanding the implications of PLEKHH3 in various cellular processes, including cell proliferation, differentiation, and apoptosis. Furthermore, these knockout cell lines can be employed to model diseases associated with dysregulated PLEKHH3 expression, offering insights into potential therapeutic targets.
The scientific importance of PLEKHH3 Gene Knockout Cell Lines is profound, particularly in research focused on cancer biology, neurobiology, and cellular metabolism. They serve as critical resources for drug discovery and validation, allowing researchers to assess the efficacy of therapeutic compounds in the context of altered PLEKHH3 activity.
Compared to alternative models, such as siRNA knockdowns or overexpression systems, these knockout cell lines provide a more stable and lasting phenotype, eliminating transient changes that could obscure experimental results. Additionally, they enable the study of the long-term effects of gene loss in a controlled environment, greatly enhancing the reliability of experimental outcomes.
The value of PLEKHH3 Gene Knockout Cell Lines extends to researchers and clinicians alike, offering a vital platform to uncover the mechanistic roles of PLEKHH3 in both normal and pathological conditions. With our dedication to precision in genetic engineering and extensive experience in providing high-quality biological products, our company is positioned to support groundbreaking research and contribute to advancements in gene-function studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.